ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The High Dose Aflibercept DME Trial"
Episode Synopsis
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
Subretinal Gene Therapy for Neovascular AMD
03/10/2025
In God we trust